XRAY vs WRBY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

XRAY

47.9
AI Score
VS
XRAY Wins

WRBY

35.1
AI Score

Investment Advisor Scores

XRAY

48score
Recommendation
HOLD

WRBY

35score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY WRBY Winner
Forward P/E 7.2359 45.045 XRAY
PEG Ratio 0.7238 0 Tie
Revenue Growth -4.1% 10.4% WRBY
Earnings Growth 15.2% -16.3% XRAY
Tradestie Score 47.9/100 35.1/100 XRAY
Profit Margin -15.0% 0.8% WRBY
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY XRAY

Relative Price Performance (Last 90 Days)

XRAY 1M: +14.8% · 3M: -15.7% WRBY 1M: +13.7% · 3M: +16.5%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $9.76

WRBY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.0 · Price: $30.15

Fundamentals Snapshot

Metric XRAY WRBY
Market Cap — —
Forward P/E 7.8 47.5
Trailing P/E — 498.3
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.5% 0.5%
Operating Margin 0.0% 0.0%
EPS -0.61 0.06
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.